Recent Articles from Business Wire

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Skyworks Solutions, Inc. (NASDAQ: SWKS) between July 30, 2024 and February 5, 2025. Skyworks describes itself as a “developer, manufacturer, and provider of analog and mixed-signal semiconductor products and solutions for numerous applications, including aerospace, automotive, broadband, cellular infrastructure, connected home, defense, entertainment and gaming, industrial, medical, smartphone, tablet, and wearables.”

Valnet Inc. (“Valnet”) and its Co-Founder and CEO, Hassan Youssef, have filed a lawsuit in the United States District Court for the District of Delaware against The Wrap News Inc. (“The Wrap”) for defamation, unfair competition and other illegal actions taken by The Wrap in connection with an article published by The Wrap on March 20, 2025 smearing Valnet and Mr. Youssef.

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights a duration of response of nearly four years from a long-term follow-up study with JELMYTO® (mitomycin) for pyelocalyceal solution, which is FDA-approved for the treatment of low-grade upper tract urothelial cancer (LG-UTUC) in adult patients.

Phixius by Nacha—a secure, peer-to-peer payment information network—announced today that ValidiFI is live on the Phixius network as an additional provider of bank account validation. Phixius now offers multiple providers of account validation, expanding the coverage of account validation data for Phixius users.

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced patient-reported outcomes following treatment of patients with low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) that showed investigational drug UGN-102 (mitomycin) for intravesical solution achieved robust and durable complete response (CR) rates without negatively impacting quality of life. The data (Moderated Poster - MP15) were presented at the AUA 2025 Annual Meeting in Las Vegas, Nevada.

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced new data from the OPTIMA II Phase 2b study of UGN‑102 (mitomycin) for intravesical solution demonstrate clinically meaningful two-year duration of response (24.2 months) by Kaplan-Meier analysis. UGN-102 is UroGen’s sustained-release formulation of mitomycin being developed for the treatment of recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers and acquirers of Geron Corporation (NASDAQ: GERN) securities between February 28, 2024 and February 25, 2025. Geron is a commercial-stage biopharmaceutical company.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from the Phase 3 KEYNOTE-689 trial evaluating KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, as a perioperative treatment regimen for patients with stage III or IVA, resected, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Results at the first interim analysis of the trial showed KEYTRUDA significantly improved event-free survival (EFS) as part of a perioperative treatment regimen with adjuvant standard of care (SOC) radiotherapy with or without cisplatin compared to adjuvant standard of care (SOC) radiotherapy with or without cisplatin alone in patients with resectable LA-HNSCC. These data are being presented for the first time today during a Plenary Session at the American Association for Cancer Research (AACR) Annual Meeting 2025 (Abstract #CT001) and were selected for the AACR press program.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of common stock of Fluence Energy, Inc. (NASDAQ: FLNC) between November 29, 2023 and February 10, 2025. Fluence describes itself as a company that “offers energy storage products and solutions, delivery services, recurring operational and maintenance services, and digital applications and solutions for energy storage and other power assets.”

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of common stock of Ready Capital Corporation (NYSE: RC) between November 7, 2024 and March 2, 2025. Ready Capital describes itself as a real estate finance company.

The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against Geron Corporation (“Geron”) (NASDAQ: GERN) on behalf of those who purchased or otherwise acquired Geron securities between February 28, 2024, and February 25, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 12, 2025.

Swimlane, AI hyperautomation for the entire security organization, today announced it has been named the “Most Valuable Pioneer” in AI maturity by QKS Group. In the 2025 QKS AI Maturity Matrix™, Swimlane ranks ahead of seven other vendors for its AI-first productization, advanced vision and agentic AI roadmap. Swimlane is ranked ahead of Palo Alto Networks, Cisco, D3, Tines, Fortinet, Torq and Anomali.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025. Maravai is a life sciences company which provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of TFI International Inc. (NYSE: TFII) between April 26, 2024 and February 19, 2025. TFI International is a transportation and logistics company.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Rocket Lab USA, Inc. (NASDAQ: RKLB) between November 12, 2024 and February 25, 2025. Rocket Lab describes itself as a “space company which provides launch services, spacecraft design services, spacecraft components, spacecraft manufacturing and other spacecraft and on-orbit management solutions.”

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of e.l.f. Beauty, Inc. (“Elf”) (NYSE: ELF) between November 1, 2023 and November 19, 2024. Elf describes itself as a company that “provides cosmetic and skin care products.”

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Quantum Computing Inc. (NASDAQ: QUBT) between March 30, 2020 and January 15, 2025. Quantum Computing describes itself as an “American company that purportedly utilizes non-linear quantum optics to deliver quantum products for high-performance computing applications.”

Innorna, a clinical-stage biotechnology company revolutionizing mRNA therapeutics with its innovative lipid nanoparticle (LNP) delivery technology, today announced the U.S. Food and Drug Administration (FDA) has granted both Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) to its investigational mRNA therapy, IN013, for treating Wilson Disease (WD). This dual achievement accelerates the clinical development of IN013, advancing Innorna’s mission to deliver transformative therapies for WD patients.

EyeMD EMR Healthcare Systems, Inc., (“EyeMD EMR” or “the Company”), a leading provider of healthcare technology software solutions purpose-built for ophthalmologists and eye care specialists, announced a significant majority growth investment from Performant Capital, a Chicago-based private equity firm focused on partnering with and scaling software and technology-enabled businesses.

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced an updated 18-month DOR of 80.6% (95% CI: 74.0, 85.7), by Kaplan-Meier estimate, from the Phase 3 ENVISION trial of UGN-102 (mitomycin) for intravesical solution, an investigational treatment for recurrent LG-IR-NMIBC. These data were featured today in an Oral Presentation Session (Abstract ID: PD12) at the AUA 2025 Annual Meeting in Las Vegas, Nevada.

Pfizer Inc. (NYSE: PFE) today announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with standard of care (SOC) Bacillus Calmette-Guérin (BCG) as induction therapy with or without maintenance in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer (NMIBC). The trial met its primary endpoint of event-free survival (EFS) by investigator assessment, demonstrating a clinically meaningful and statistically significant improvement with sasanlimab in combination with BCG (induction and maintenance) as compared to BCG alone (induction and maintenance): Hazard Ratio (HR) of 0.68; 95% Confidence Interval (CI), 0.49-0.94; 2-sided p=0.019; median EFS not yet reached. These findings show a 32% reduction in risk of disease-related events, including high-grade disease recurrence or progression, with the sasanlimab combination regimen as compared with SOC treatment alone. Pre-specified subgroup analyses for patients harboring higher risk disease showed consistent benefit with EFS HR of 0.63 (0.41, 0.96) for T1 disease, and EFS HR 0.53 (0.29, 0.98) for those with CIS disease.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Napco Security Technologies, Inc. (“Napco” or “the Company”) (NASDAQ: NSSC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced encouraging safety data from the Phase 1 dose-escalation study for UGN-301 (zalifrelimab) intravesical solution, an investigational drug in development for the treatment of recurrent non-muscle invasive bladder cancer (NMIBC).

Diamond Comic Distributors (“Diamond” or “the Company”), today announced that it will no longer be moving forward in the transaction process with Alliance Entertainment.

Please replace the release dated April 23, 2025, with the following corrected version due to multiple revisions.

US Metro Bancorp (OTCQX: USMT): US Metro Bancorp (“Bancorp”) is a bank holding company, with a single subsidiary, US Metro Bank (“Bank”). On a consolidated basis, Bancorp earned $2.6 million in the first quarter of 2025, compared to $1.7 million in the fourth quarter of 2024. For the three months ending March 31, 2025, the consolidated Bancorp earned $2.6 million compared to $1.5 million for the three months ending March 31, 2024. On a year-to-date basis, Bancorp recorded an annualized return on average assets (“ROAA”) of 0.73% and an annualized return on average equity (“ROAE”) of 10.10%. With 16,520,000 shares outstanding, earnings per share (“EPS”) for the first quarter of 2025 was $0.16 compared to $0.11 in the fourth quarter of 2024. For the three months ending March 31, 2025, EPS was $0.16 compared to $0.09 for the three months ending March 31, 2024. On March 31, 2025, Bancorp’s book value per share was $6.29 compared to $5.87 a year earlier.

Marti Technologies, Inc. (“Marti”) (NYSE American: MRT), Türkiye’s leading mobility super app, will announce its full year 2024 financial and operational results before the U.S. markets open on Tuesday, April 29, 2025.

Resecurity, a U.S.-based cybersecurity company specializing in threat intelligence and digital risk management, successfully exhibited at MILIPOL India 2025, held from April 23–25 at India International Convention and Expo Centre (IICC), Dwarka, New Delhi. The event served as a premier meeting point for global leaders in homeland security, defense technology, and public safety.

The Law Offices of Frank R. Cruz reminds investors of the upcoming April 28, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Quantum Computing Inc. ("Quantum Computing" or the Company") (NASDAQ: QUBT) securities between March 30, 2020 and January 15, 2025, inclusive (the “Class Period”).

Visual Matrix, a leading provider of advanced technology solutions for the hospitality industry, announced a new partnership with Dubai’s Best Western Premier M Four Hotel. The Best Western Premier will receive access to Visual Matrix’s cutting-edge Property Management System, supporting full mobile operations and promoting greater efficiency and profitability.

Orbia Advance Corporation, S.A.B. de C.V. (“Orbia”) (BMV: ORBIA*), announces that today, it launched an offer to purchase for cash (the “Tender Offer”) any and all of the outstanding 1.875% Senior Notes due 2026 issued by Orbia (the “Notes”).

KBRA assigns preliminary ratings to six classes of mortgage pass-through notes from GCAT 2025-NQM1 Trust, a $438.2 million non-prime RMBS transaction. The underlying collateral, comprising 764 residential mortgages, is characterized by a significant concentration of loans underwritten using alternative income documentation. Borrowers in the subject pool possess a non-zero WA original credit score of 756 and exhibit modest equity in each mortgaged property, with WA LTV and combined LTV (CLTV) ratios of 69.5% and 69.5%, respectively.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Landstar System, Inc. (“Landstar” or the “Company”) (NASDAQ: LSTR) investors concerning the Company’s possible violations of the federal securities laws.

First paragraph, first sentence of release should read: University of Phoenix is pleased to announce the release of its new Admissions Guide as an extensive resource helping students and prospective students understand the admissions process including degree opportunities, programmatic accreditation, student support services, and ways to reduce education costs. (instead of: University of Phoenix is pleased to announce the release of its new as an extensive resource helping students and prospective students understand the admissions process including degree opportunities, programmatic accreditation, student support services, and ways to reduce education costs).

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) resulting from allegations that Aldeyra may have issued materially misleading business information to the investing public.

Law Offices of Howard G. Smith announces an investigation on behalf of Landstar System, Inc. (“Landstar” or the “Company”) (NASDAQ: LSTR) investors concerning the Company’s possible violations of federal securities laws.

As part of its Earth Week celebration, Fullerton College held a ribbon cutting ceremony to commemorate the completion of a new solar canopy system developed in partnership with ForeFront Power, a leading developer and asset manager of commercial and industrial-scale solar energy and storage projects. The 1 megawatt-DC (MW DC) solar parking canopy array, located in Student Parking Lot 5 adjacent to Sherbeck Field, is projected to save Fullerton College nearly $6 million in energy costs over the next 20 years.

Lubrizol requests that their press release NewsItemId: 20250425022439 “Lubrizol Enters Nutraceutical Ingredient Distribution Partnership with Palmer Holland Inc. to Expand U.S. Reach” be killed.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into NAPCO Security Technologies, Inc. (NasdaqGS: NSSC).

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Virtu Financial, Inc. (NasdaqGS: VIRT).

Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced the election of Lynda Cloud to its Board of Directors, effective April 23, 2025. This appointment reflects Herbalife’s continued commitment to innovation, digital transformation, and personalized wellness.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Extreme Networks, Inc. (NasdaqGS: EXTR).

Compass Minerals (NYSE: CMP), a leading global provider of essential minerals, will release its second-quarter fiscal 2025 results Wednesday, May 7, 2025, after the markets close. The company’s president and CEO, Edward C. Dowling Jr., and CFO, Peter Fjellman, will discuss these results on a conference call on Thursday, May 8, 2025, at 9:30 a.m. ET.

Energy Vault Holdings, Inc. (“Energy Vault”) (NYSE: NRGV), a global energy storage company today announced that, effective on March 5, 2025, the Compensation Committee of Energy Vault’s Board of Directors granted to 12 new, non-executive employees, restricted stock unit awards covering 637,600 shares of its common stock under the Energy Vault Holdings, Inc. 2022 Employment Inducement Award Plan (as amended and/or restated, the “Inducement Award Plan”). The restricted stock units were granted as inducements material to the employees entering into employment with Energy Vault in accordance with New York Stock Exchange Listing Rule 303A.08.

Sunny Day, the beautiful new song and video from Antigua’s Reggae Ambassador, Causion, has officially launched on all major streaming platforms.

Today, consumer-rights law firm FeganScott announced that it has launched an investigation into Blue Shield of California, one of the largest healthcare insurance providers in the country, following confirmation from the company and the United States Department of Health and Human Services that the company had shared private health information and site user data with Google’s advertising products, Google Ads and Google Analytics.

Researchers with City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, will present more than 74 chaired, plenary, educational, minisymposium, poster and other sessions on innovative clinical trial results, breakthrough diagnostic techniques and advances in treatment options at the AACR Annual Meeting, which started April 25 and ends April 30 in Chicago.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Pacific Premier Bancorp, Inc. (NasdaqGS: PPBI) to Columbia Banking System, Inc. (NasdaqGS: COLB). Under the terms of the proposed transaction, shareholders of Pacific will receive 0.9150 of a share of Columbia for each share of Pacific that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Veritone, Inc. (NASDAQ: VERI), a leader in building human-centered enterprise AI solutions, today announced the details of its first quarter 2025 financial results conference call.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Newmont Corporation (NYSE: NEM).

Innovex International, Inc. (NYSE: INVX) (the “Company” or “Innovex”) announced its entry into a definitive agreement to sell its facility located at 6401 North Eldridge Pkwy, Houston, Texas 77041 (the “Property”). The sale price for the Property is $95.0 million, subject to adjustments, and the sale is expected to close in the third quarter of 2025.

Sallie Mae® (Nasdaq: SLM), formally SLM Corporation, today announced the appointments of Dr. Daniel Greenstein and Mr. Gary Millerchip to its board of directors, effective April 23, 2025.

Ares Commercial Real Estate Corporation (NYSE: ACRE) announced today that it will report earnings for the first quarter ended March 31, 2025 on Wednesday, May 7, 2025 prior to the opening of the New York Stock Exchange. Ares Commercial Real Estate Corporation will hold its webcast/conference call on the same day at 12:00 p.m. Eastern Time to discuss its first quarter ended March 31, 2025 financial results.

N-able, Inc. (NYSE:NABL), a global software company delivering a unified cyber resiliency platform to manage, secure, and recover, today announced that it will host a conference call to discuss its financial results for the first quarter of 2025 at 8:30 a.m. ET on May 8, 2025.

Mettler-Toledo International Inc. (NYSE:MTD) today announced it will present at the BofA Securities 2025 Healthcare Conference on Wednesday, May 14, 2025, at 4:20pm Pacific Time (7:20pm Eastern Time). A live webcast of the presentation will be available on the Company’s investor relations website at investor.mt.com.

VTEX (NYSE: VTEX), the backbone for connected commerce, announced today that the following matters were approved in its annual general meeting of shareholders (“AGM”) held on April 25, 2025:

NYSE today reported short interest as of the close of business on the settlement date of April 15, 2025.

On April 23, 2025, Wellsboro, PA-based Citizens & Northern Corporation (NASDAQ: CZNC) ("C&N"), parent company of Citizens & Northern Bank, and West Milton, PA-based Susquehanna Community Financial, Inc. (OTCPK: SQCF) ("Suequehanna Community"), parent company of Susquehanna Community Bank, jointly announced that they had entered into a definitive agreement pursuant to which Susquehanna Community Financial, Inc. would merge with and into Citizens & Northern Corporation, and Susquehanna Community Bank would merge with and into Citizens & Northern Bank. The transaction, valued at $44.3 million (P/TBV: 1.3x), is an all-stock deal expected to close in 4Q25 pending regulatory approval. Under the agreement, Chris Trate, current SQCF Board Chairman, would be appointed to C&N's board of directors. In addition, Dave Runk, SQCF's CEO, would become a member of the Citizens & Northern Bank executive team as EVP and Strategic Advisor, and Jeffrey Hollenbach, SQCF's President and COO, would lead the Susquehanna market as Region President.

Raptor Technologies, the leader in school safety software solutions, is proud to announce new integrations with key video analytics providers Scylla and Vyze. These advanced tools enhance the Raptor Emergency Management System, equipping schools with proactive threat detection capabilities and automated emergency responses. These advancements empower schools to act with greater speed and intelligence, improving overall campus safety.

The Law Offices of Frank R. Cruz announces an investigation of Landstar System, Inc. (“Landstar” or the “Company”) (NASDAQ: LSTR) on behalf of investors concerning the Company’s possible violations of federal securities laws.

Wolverine World Wide, Inc. (NYSE: WWW) today announced that it expects to report its first quarter fiscal 2025 financial results on Thursday, May 8, 2025, at approximately 6:30 a.m. ET. Following the press release, the Company will host a conference call at 7:30 a.m. ET to review results and discuss current business trends.

The Badger Meter, Inc. (NYSE:BMI) Board of Directors today declared a regular quarterly cash dividend of $0.34 per share to shareholders of record on May 23, 2025, payable June 6, 2025.

Amcor plc (“Amcor”) (NYSE: AMCR, ASX: AMC) and Berry Global Group, Inc. (“Berry”) (NYSE: BERY) today announced the European Commission (EC) has granted unconditional approval under the EU Merger Regulation for the previously announced combination of the two companies, satisfying the final regulatory clearance required. In accordance with the merger agreement, this enables the companies to complete the remaining steps towards closing. The transaction is expected to close on April 30, 2025, subject to the satisfaction or waiver of certain other closing conditions.

Spire Global, Inc. (NYSE: SPIR) (“Spire” or “the Company”), a global provider of space-based data, analytics and space services, completed the previously announced sale of its maritime business to Kpler for approximately $233.5 million, before adjustments, plus a $7.5 million agreement for services over a twelve-month period, post close. Spire used the proceeds of the sale to retire all outstanding debt. The remaining proceeds will be used to invest in near-term growth opportunities.

Repay Holdings Corporation (NASDAQ: RPAY) (“REPAY” or the “Company”), a leading provider of integrated payment processing solutions, today announced that Tim Murphy will be stepping down from his role as Chief Financial Officer to pursue an opportunity outside of the payments industry with a private equity-backed company. Mr. Murphy has served as the Chief Financial Officer of REPAY since 2014, and helped guide the company to its successful public listing in 2019 while also completing eleven acquisitions during his tenure. Mr. Murphy will remain with the Company until May 15, 2025 to help facilitate a smooth transition. Upon his departure from the Company, Thomas Sullivan will be appointed as Interim Chief Financial Officer until a permanent replacement can be identified. Mr. Sullivan is currently the Company’s Chief Accounting Officer.

Cardlytics, Inc. (NASDAQ: CDLX) today announced that on April 24, 2025, the Compensation Committee of Cardlytics’ Board of Directors granted an aggregate of 124,050 restricted stock units of Cardlytics to 11 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”).

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to five new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were approved and issued on April 21, 2025, in accordance with Nasdaq Listing Rule 5635(c)(4).

Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of Denmark Sausage Co. dba Denmark Foods/Arizona Fresh to Premium Brands. The acquisition closed March 3, 2025.

The Avangrid Foundation, the philanthropic arm of leading energy company Avangrid Inc., a member of the Iberdrola Group, and Central Maine Power (CMP) joined Kennebec Valley Community College (KVCC) in a ribbon-cutting ceremony for their Electrical Lineworker Technology Program. KVCC unveiled their new Derrick Digger Truck, a state-of-the-art addition to the program’s training resources.

PENN Entertainment, Inc. (“PENN” or the “Company”) (Nasdaq: PENN) today announced that it intends to nominate Johnny Hartnett and Carlos Ruisanchez for election to its Board of Directors following discussions with HG Vora Capital Management, LLC (“HG Vora”). Ron Naples has informed the Board that he will retire from the Board, effective immediately. Barbara Shattuck Kohn and Saul Reibstein have notified the Company that they will not stand for reelection at the 2025 Annual Meeting of Shareholders. The Board now comprises eight directors, seven of whom are independent.

Kardium Inc., a private medical device company that’s advancing the way the world treats atrial fibrillation (AF), announced late-breaking, one-year clinical trial results for its innovative pulsed field ablation (PFA) device—the Globe PF System. These pivotal findings from the PULSAR IDE study were announced at the Heart Rhythm Society (HRS) meeting in San Diego1, highlighting the safety and efficacy data of the Globe PF System, which is currently under PMA review with the US FDA.

BancPlus Corporation, the holding company for BankPlus, today announced that on April 24, 2025, its Board of Directors declared a quarterly cash dividend of $0.50 per share of its common stock. The cash dividend is equivalent to an annualized dividend of $2.00 per share. The cash dividend will be paid on June 13, 2025, to shareholders of record as of the close of business on May 15, 2025.

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today noted that Akeso, Inc. (Akeso, HKEX Code: 9926.HK) announced that ivonescimab was approved by the Chinese Health Authorities, the National Medical Products Administration (NMPA), for a second indication based on the results of the Phase III clinical trial, HARMONi-2 or AK112-303. HARMONi-2 evaluated monotherapy ivonescimab against monotherapy pembrolizumab in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have positive PD-L1 expression. HARMONi-2 is a single region, multi-center, Phase III study conducted in China sponsored by Akeso with all relevant data exclusively generated, managed, and analyzed by Akeso.

AM Best has affirmed the Financial Strength Rating of A+ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “aa” (Superior) of Principal Life Insurance Company and Principal National Life Insurance Company. Both are life insurance operating companies of Principal Financial Group, Inc. (PFG) [NASDAQ: PFG] and collectively referred to as Principal. Concurrently, AM Best has affirmed the Long-Term ICRs of “a” (Excellent) of Principal Financial Services, Inc. and PFG, as well as the group’s Long-Term Issue Credit Ratings (Long-Term IRs). In addition, AM Best has affirmed the group’s Short-Term Issue Credit Rating (Short-Term IR). The outlook of these Credit Ratings (ratings) is stable. (Please see below for a detailed listing of the Long- and Short-Term IRs.) All companies are headquartered in Des Moines, IA.

Latino Community Foundation: